Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Global health resource utilization associated with pacemaker complications.

Catherine Waweru1, Anna Steenrod2, Claudia Wolff3

  • 1a Medtronic, plc , Mounds View , MN , USA.

Journal of Medical Economics
|April 19, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Mavacamten on Disease-Related Symptoms in Patients With Obstructive Hypertrophic Cardiomyopathy: HCMSQ Outcomes in EXPLORER-HCM.

Journal of cardiac failure·2026
Same author

Cost-Effectiveness of Differential Target Multiplexed Spinal Cord Stimulation for the Treatment of PSPS Type 1 from the Belgian Perspective.

Journal of pain research·2026
Same author

A Simultaneous Assessment of Efficacy and Safety of Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease.

Clinical therapeutics·2026
Same author

Impact of timing of nontuberculous mycobacterial pulmonary disease antibiotic initiation on hospitalizations in Japan.

Respiratory investigation·2026
Same author

Erratum: Cost-Effectiveness of an Absorbable Antibacterial Envelope for Infection Control in Cardiac Implantable Electronic Device Procedures in Spain.

Journal of health economics and outcomes research·2026
Same author

Cost-Effectiveness of an Absorbable Antibacterial Envelope for Infection Control in Cardiac Implantable Electronic Device Procedures in Spain.

Journal of health economics and outcomes research·2026

Pacemaker complication management varies in health resource utilization across regions, with infections being most resource-intensive. This study estimated these costs using a Delphi panel approach.

Area of Science:

  • Cardiology and Medical Device Management
  • Health Economics and Resource Utilization

Background:

  • Pacemaker implantation is common, but complications necessitate significant healthcare resources.
  • Understanding health resource utilization (HRU) for pacemaker complications is crucial for cost-effectiveness analysis and healthcare planning.
  • Chronic pacemaker complications include infections, lead issues, and deep venous thrombosis (DVT).

Purpose of the Study:

  • To estimate the health resource utilization (HRU) associated with managing chronic pacemaker complications.
  • To compare HRU across different geographical healthcare systems.
  • To establish consensus on resource use for pacemaker implantation and complication management.

Main Methods:

  • A Delphi panel survey involving electrophysiologists (EPs) from Western Europe, Australia, Japan, and North America.
Keywords:
ComplicationsDelphi panelHealth resource utilizationPacemaker

Related Experiment Videos

  • Web-based surveys focused on HRU for pacemaker infections, lead fractures/breaches, and upper extremity DVT.
  • Iterative survey rounds were used to reach consensus on treatment and resource utilization.

    • Main Results:

    • Consensus was achieved on HRU for pacemaker implantation and chronic complications.
    • Pacemaker infections were the most resource-intensive, requiring extensive intravenous antibiotics and procedures.
    • Deep venous thrombosis (DVT) was the least resource-intensive complication; Japan reported longer hospital stays.

    Conclusions:

    • The Delphi technique effectively estimated resource utilization for chronic pacemaker complications.
    • Estimates can inform cost analyses of pacemaker complications across diverse healthcare regions.
    • The study provides a foundation for understanding and managing the economic impact of pacemaker complications.